{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:52:48Z","timestamp":1784605968845,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.urolonc.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T08:27:18Z","timestamp":1711787238000},"page":"176.e9-176.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI"],"prefix":"10.1016","volume":"42","author":[{"given":"Longchao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.02.008_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0002","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00345-015-1548-x","article-title":"Impact of 2004 ISUP\/WHO classification on bladder cancer grading","volume":"33","author":"Lokeshwar","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0003","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","article-title":"Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature","volume":"68","author":"Kluth","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0004","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN Clinical Practice Guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0008","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0009","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0010","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.juro.2012.09.084","article-title":"Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance","volume":"189","author":"Linton","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0011","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.ju.0000149163.08521.69","article-title":"A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database","volume":"173","author":"Mariappan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0012","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0013","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0014","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/bju.12245","article-title":"Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy","volume":"113","author":"Ark","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eururo.2006.05.021","article-title":"Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy","volume":"51","author":"Shariat","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0016","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-410X.2012.10939.x","article-title":"Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome","volume":"110","author":"Turker","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2665711","article-title":"A novel nomogram and risk classification system predicting the cancer-specific survival of muscle-invasive bladder cancer patients after partial cystectomy","author":"Zhan","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.2503080723","article-title":"Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria","volume":"251","author":"Abou-El-Ghar","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1148\/radiol.2511080873","article-title":"Urinary bladder cancer: diffusion-weighted MR imaging\u2013accuracy for diagnosing T stage and estimating histologic grade","volume":"251","author":"Takeuchi","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0020","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2214\/AJR.17.17798","article-title":"DWI as an imaging biomarker for bladder cancer","volume":"208","author":"Yoshida","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.02.008_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jmri.24148","article-title":"Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer","volume":"39","author":"Kobayashi","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0022","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2214\/AJR.19.21668","article-title":"Application of R2* and apparent diffusion coefficient in estimating tumor grade and T category of bladder cancer","volume":"214","author":"Wang","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0023","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.acra.2018.04.016","article-title":"Comparison of the diagnostic value of monoexponential, biexponential, and stretched exponential diffusion-weighted MRI in differentiating tumor stage and histological grade of bladder cancer","volume":"26","author":"Wang","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0024","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0026","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/cancers13246199","article-title":"Prediction of clinically significant cancer using radiomics features of pre-biopsy of multiparametric MRI in men suspected of prostate cancer","volume":"13","author":"Ogbonnaya","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0027","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.3390\/cancers13235921","article-title":"Applications of radiomics and radiogenomics in high-grade gliomas in the era of precision medicine","volume":"13","author":"Fathi Kazerooni","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0028","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.3390\/cancers13225864","article-title":"Radiomics models for predicting microvascular invasion in hepatocellular carcinoma: a systematic review and radiomics quality score assessment","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0029","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","article-title":"Radiomics in breast cancer classification and prediction","volume":"72","author":"Conti","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0030","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41467-020-15027-z","article-title":"Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0031","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jmri.25669","article-title":"Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging","volume":"46","author":"Zhang","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0032","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1007\/s00330-019-06222-8","article-title":"Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors","volume":"29","author":"Wang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0033","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1007\/s00261-021-03108-6","article-title":"Integrating multiparametric MRI radiomics features and the vesical imaging-reporting and data system (VI-RADS) for bladder cancer grading","volume":"46","author":"Zheng","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0034","series-title":"Nonparametric Statistics for the Behavioral Sciences","author":"Siegel","year":"1988"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0036","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00261-021-03367-3","article-title":"Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment","volume":"47","author":"Gauthier","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0037","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0038","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2020203644","article-title":"Risk of nephrogenic systemic fibrosis from gadoxetic acid in patients with severe kidney disease","volume":"297","author":"Davenport","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0039","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/jmri.27132","article-title":"Noninvasive prediction of high-grade prostate cancer via biparametric MRI radiomics","volume":"52","author":"Gong","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0040","first-page":"171","article-title":"A pilot study of radiomics signature based on biparametric MRI for preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma","volume":"29","author":"He","year":"2021","journal-title":"J Xray Sci Technol"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0041","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13246-021-01022-1","article-title":"Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation","volume":"44","author":"Ji","year":"2021","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.urolonc.2024.02.008_bib0042","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.3390\/cancers13236065","article-title":"Prediction of prostate cancer disease aggressiveness using bi-parametric MRI radiomics","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:26:21Z","timestamp":1713997581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924003387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1078143924003387"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.02.008","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3188308\/v1","asserted-by":"object"}]},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}